Sun Pharmaceutical Industries Ltd.

Financial

	Sun Pharma Inds.	Cipla	Torrent Pharma
Operational Metrics
API Sector
US DMF Filings	518.0 .	2204.0 .	n/a
US DMF Approval	397.0 .	n/a	n/a
Pharmaceutical Sector
Number of ANDA's Filed in USA	650.0 .	283.0 .	168.0 .
Number of ANDA's Approved By USFDA	541.0 .	204.0 .	132.0 .
Domestic Sales Growth - YoY	12.4 %	7.1 %	12.8 %
R&D as a % of Total Sales	6.3 %	5.1 %	5.4 %
Financials
5 yr Average ROE	10.31 %	12.48 %	20.0 %
5yr average Equity Multiplier	1.37	1.31	2.34
5yr Average Asset Turnover Ratio	0.55	0.78	0.65
5yr Avg Net Profit Margin	13.53 %	12.29 %	13.21 %
Price to Book	6.26	4.42	14.99
P/E	37.87	25.11	60.42
5yr Avg Cash Conversion Cycle	-31.93 Days	-4.58 Days	-189.03 Days
Inventory Days	60.94 Days	58.34 Days	54.5 Days
Days Receivable	85.38 Days	45.49 Days	41.38 Days
Days Payable	165.78 Days	110.05 Days	318.84 Days
5yr Average Interest Coverage Ratio	35.55	33.93	5.79
5yr Avg ROCE	16.04 %	17.45 %	23.72 %
5yr Avg Operating Profit Margin	24.95 %	21.56 %	29.52 %
5 yr average Debt to Equity	0.09	0.07	0.83
5yr CAGR Net Profit	20.53 %	21.66 %	10.08 %
5yr Average Return on Assets	7.59 %	9.64 %	8.58 %
Shareholdings
Promoter Holding	54.48 %	29.2 %	68.31 %
Share Pledged by Promoters	0.88 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-4.43 %	-2.94 %
Change in Mutual Fund Holding (3 Yrs)	0.58 %	6.6 %	-2.45 %

Business

	Sun Pharma Inds.	Cipla	Torrent Pharma
Product Wise Break-Up	Product Wise Break-Up US Formulations 33.0 India Branded Generics 32.0 Emerging Market 18.0 Western Europe & Other Markets 13.0 Active Pharmaceutical Ingredient (API) 4.0 New ventures 0 Pharmaceuticals 0 Domestic formulations 0 Contract Manf. 0 Brazil/Latam 0 Germany/Europe 0	Product Wise Break-Up Germany/Europe 0 India Branded Generics 0 New ventures 4.79 Active Pharmaceutical Ingredient (API) 0 Brazil/Latam 0 Emerging Market 0 US Formulations 0 Domestic formulations 0 Contract Manf. 0 Western Europe & Other Markets 0 Pharmaceutical 95.21	Product Wise Break-Up Germany 13.15 India Branded Generics 0 New ventures 0 Active Pharmaceutical Ingredient (API) 0 Brazil 8.98 Emerging Market 0 US Formulations 20.71 Domestic Formulations 42.15 Contract Manufacturing 6.15 Western Europe & Other Markets 0 Pharmaceuticals 0 Others 8.86
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Central Nervous System (CNS) 20.0 Cardiac Science 17.0 Gastro Intestinal 14.0 Anti - Diabetes 8.0 Pain Management 7.0 Anti-Infective 6.0 Respiratory Systems 5.0 Vitamins / Minerals / Nutrients 5.0 Gynecology 4.0 Dermatology 4.0 Ophthalmology 3.0 Urology 3.0 Anti-infectives 0 Cardiac 0 Gastro Intestinal 0 Antivirals 0 Derma 0 Neuro /CNS 0 Gynaec. 0 Vitamins 0 Antineoplast 0 Opthal/Otologicals 0 Oncology 0 Anti Diabetic 0 Others 4.0	Therapeutic Area Wise Break-Up - Domestic Urology 4.7 Cardiac Science 0 Respiratory Systems 0 Vitamins / Minerals / Nutrients 0 Anti - Diabetes 5.6 Vitamins 0 Ophthalmology 0 Central Nervous System (CNS) 0 Anti-Infective 14.0 Central Nervous System (CNS) 3.3 Gynecology 0 Anti - Diabetes 0 Gynaec. 0 Antivirals 0 Cardiac Science 11.4 Dermatology 0 Gastro Intestinal 5.4 Oncology 0 Antineoplast 0 Pain Management 0 Anti-Infective 0 Ophthalmology 3.0 Derma 3.3 Others 49.3	-
Location Wise Break-Up	Location Wise Break-Up USA 33.26 India 32.24 Emerging Market 19.35 Rest of the World 15.15 SAGA 0 Europe 0 Global API 0 North America 0 Germany 0 Brazil 0	Location Wise Break-Up Brazil 0 India 44.0 Global API 2.0 Rest of the World 0 Europe 12.0 Emerging Market 0 USA 0 North America 27.0 SAGA 14.0 Germany 0 Others 1.0	Location Wise Break-Up Brazil 10.36 India 56.28 Global API 0 Rest of the World 0 Europe 0 Emerging Market 0 USA 9.65 North America 0 SAGA 0 Germany 10.04 Others 13.67

Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd.

SIGN UP FOR FREE